Nos publications

GELUCIRE® 4414 for type IV lipid based formulations and their in vitro in vivo performance evaluation

  • Poster

AAPS PharmSci360 – Philadelphia (USA)  - 2021

In this study, Gelucire® 44/14 in type IV lipid-based formulation has been evaluated to increase the solubility and in vivo performance of ticagrelor. 

Télécharger (.pdf - 919.72 Ko)

The Gelucire® family

  • Whitepaper

Pharma Excipients  - 2018

Gattefossé

In-vitro investigation regarding the effects of Gelucire® 44/14 and Labrasol® ALF on the secretory intestinal transport of P-gp substrates

  • Scientific publication

International Journal of Pharmaceutics, Volume 515, Issues 1–2, Pages 293-299 https://doi.org/10.1016/j.ijpharm.2016.10.012 - déc 2016

Océane Dubray, Vincent Jannin, Fréderic Demarne, Yann Pellequer, Alf Lamprecht, Arnaud Béduneau

Formulation of a self-emulsifying lipid formulation of curcumin

  • Poster

AAPS Annual Meeting & Exposition – San Diego (USA)  - 2014

Vincent Jannin, Camille Dumont, Hamza Benhaddou, Stéphanie Chevrier, Yann Chavant, Christophe Voutsinas, Frédéric Demarne

Télécharger (.pdf - 355.83 Ko)